Clinical Trials
3 trialsNCT02197169 2018-07-16
TARGET-I
DNAtrix, Inc.
Phase 1 Completed
NCT00047632 2007-11-01
Safety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and Peritoneal Cancer
InterMune
Phase 3 Terminated
NCT00057447 2007-11-01
Safety of Interferon Gamma-1b With Rituximab in Non-Hodgkin's Lymphoma Patients
InterMune
Phase 1/2 Terminated